Li Feng Qin - Net Worth and Insider Trading

Li Feng Qin Net Worth

The estimated net worth of Li Feng Qin is at least $3 Million dollars as of 2024-06-22. Li Feng Qin is the Director of Tonghua Dongbao Pharmaceutical Co Ltd and owns about 360,573 shares of Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) stock worth over $3 Million. Details can be seen in Li Feng Qin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Li Feng Qin has not made any transactions after 2019-09-10 and currently still holds the listed stock(s).

Transaction Summary of Li Feng Qin

To

Li Feng Qin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Li Feng Qin owns 1 companies in total, including Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) .

Click here to see the complete history of Li Feng Qin’s form 4 insider trades.

Insider Ownership Summary of Li Feng Qin

Ticker Comapny Transaction Date Type of Owner
SHSE:600867 Tonghua Dongbao Pharmaceutical Co Ltd 2019-09-10 Director

Li Feng Qin Latest Holdings Summary

Li Feng Qin currently owns a total of 1 stock. Li Feng Qin owns 360,573 shares of Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) as of September 10, 2019, with a value of $3 Million.

Latest Holdings of Li Feng Qin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SHSE:600867 Tonghua Dongbao Pharmaceutical Co Ltd 2019-09-10 360,573 8.85 3,191,071

Holding Weightings of Li Feng Qin


Li Feng Qin Form 4 Trading Tracker

According to the SEC Form 4 filings, Li Feng Qin has made a total of 2 transactions in Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Tonghua Dongbao Pharmaceutical Co Ltd is the sale of 50,000 shares on September 10, 2019, which brought Li Feng Qin around $965,000.

Insider Trading History of Li Feng Qin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Li Feng Qin Trading Performance

GuruFocus tracks the stock performance after each of Li Feng Qin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Li Feng Qin is 17.76%. GuruFocus also compares Li Feng Qin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Li Feng Qin within 3 months outperforms 4 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Li Feng Qin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Li Feng Qin

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
4 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 17.55 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 17.47 LIMIT LIMIT LIMIT LIMIT LIMIT

Li Feng Qin Ownership Network

Ownership Network List of Li Feng Qin

No Data

Ownership Network Relation of Li Feng Qin

Insider Network Chart

Li Feng Qin Owned Company Details

What does Tonghua Dongbao Pharmaceutical Co Ltd do?

Who are the key executives at Tonghua Dongbao Pharmaceutical Co Ltd?

Li Feng Qin is the Director of Tonghua Dongbao Pharmaceutical Co Ltd. Other key executives at Tonghua Dongbao Pharmaceutical Co Ltd include Supervisors Cheng Jian Qiu , senior management Chen Hong , and Supervisors Wang Dian Duo .

Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tonghua Dongbao Pharmaceutical Co Ltd Insider Transactions

No Available Data

Li Feng Qin Mailing Address

Above is the net worth, insider trading, and ownership report for Li Feng Qin. Currently GuruFocus does not have mailing address information for Li Feng Qin.

Discussions on Li Feng Qin

No discussions yet.